FDA Inspection
Bora Pharmaceuticals Injectables IncBora Pharmaceuticals Injectables Inc – FDA Inspection, Feb 18, 2022
Record Details
This FDA Inspection record concerns Bora Pharmaceuticals Injectables Inc, with an inspection on February 18, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 18, 2022
- Product Type
- Drugs
View Company Profile
ID · 80084db0-1146-4974-9b63-31bb834296ee
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1162959
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Bora Pharmaceuticals Injectables Inc
16| Date | Classification | Office | Project area |
|---|---|---|---|
| March 20, 2026 | Not classified | Baltimore District Office | Drug Quality Assurance |
| July 25, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 10, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 16, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 10, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bora Pharmaceuticals Injectables Inc
- FDA Inspection 1308344 - 2026-03-20
- FDA Inspection 1236852 - 2024-07-25
- FDA Inspection 1215798 - 2023-08-10
- FDA Inspection 1140286 - 2021-04-16
- FDA Inspection 1091850 - 2019-05-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.